Literature DB >> 31802190

Is ascites CEA a risk factor for peritoneal carcinomatosis in colorectal cancer?: a long-term follow-up study.

Byung Chul Kim1,2, Jung Hoon Bae1, Sun Min Park3, Dae Youn Won1, In Kyu Lee4.   

Abstract

PURPOSE: Our previous study reported that carcinoembryonic antigen (CEA) levels in peritoneal fluid were significantly correlated with the prevalence of peritoneal carcinomatosis (PC) in colorectal cancer (CRC). The purpose of this study was a long-term follow up of the author's previous study, as well as the identification of correlations with the known risk factors of PC and the comparison of the predictive power of PC in CRC.
METHODS: A total of 495 patients without PC who underwent CRC operations at St. Mary's Hospital, The Catholic University of Korea, from January 2006 to November 2014 were included in this study. Tumor markers of peritoneal fluid sampled at the beginning of each operation were prospectively analyzed and compared with the known risk factors for PC in CRC.
RESULTS: Multivariate analysis of PC revealed that T4 cancer (OR 5.143, 95% CI 1.400-18.897, p = 0.014), T3 mucinous cancer (OR 17.480, 95% CI 1.577-193.714, p = 0.020), obstructed tumors (OR 6.030, 95% CI 1.627-22.343, p = 0.007), and peritoneal fluid CEA above 5 ng/dl (OR 4.073, 95% CI 1.315-12.615, p = 0.015) were significant risk factors. T4 cancer, obstructed tumors, and peritoneal fluid CEA above 5 ng/dl showed correlations with cancer-free survival. Generally, higher CEA levels in peritoneal fluid were correlated with previously known risk factors for PC in CRC.
CONCLUSION: Peritoneal fluid CEA has predictive value for PC and prognostic value in CRC. Therefore, we recommend routinely performing ascites CEA analysis in colorectal cancer surgery.

Entities:  

Keywords:  Ascitic fluid; Carcinoembryonic antigen; Colorectal neoplasms; Peritoneal neoplasms

Year:  2019        PMID: 31802190     DOI: 10.1007/s00384-019-03448-2

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  28 in total

1.  Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy.

Authors:  D Elias; F Blot; A El Otmany; S Antoun; P Lasser; V Boige; P Rougier; M Ducreux
Journal:  Cancer       Date:  2001-07-01       Impact factor: 6.860

2.  Incidence and prognostic value of positive peritoneal cytology in colorectal cancer.

Authors:  I Kanellos; H Demetriades; E Zintzaras; A Mandrali; I Mantzoros; D Betsis
Journal:  Dis Colon Rectum       Date:  2003-04       Impact factor: 4.585

3.  Improved survival in cancer of the colon and rectum in Sweden.

Authors:  H Birgisson; M Talbäck; U Gunnarsson; L Påhlman; B Glimelius
Journal:  Eur J Surg Oncol       Date:  2005-10       Impact factor: 4.424

4.  Prognostic value of microscopic peritoneal dissemination: comparison between colon and gastric cancer.

Authors:  P Vogel; J Rüschoff; S Kümmel; H Zirngibl; F Hofstädter; W Hohenberger; K W Jauch
Journal:  Dis Colon Rectum       Date:  2000-01       Impact factor: 4.585

5.  Two-stage radical gastrectomy for perforated gastric cancer.

Authors:  T Lehnert; K Buhl; M Dueck; U Hinz; C Herfarth
Journal:  Eur J Surg Oncol       Date:  2000-12       Impact factor: 4.424

6.  Long-term prognostic value of conventional peritoneal cytology after curative resection for colorectal carcinoma.

Authors:  Seiichiro Yamamoto; Takayuki Akasu; Shin Fujita; Yoshihiro Moriya
Journal:  Jpn J Clin Oncol       Date:  2003-01       Impact factor: 3.019

Review 7.  Patient selection and treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer.

Authors:  P H Sugarbaker
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

8.  Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.

Authors:  Vic J Verwaal; Serge van Ruth; Eeclo de Bree; Gooike W van Sloothen; Harm van Tinteren; Henk Boot; Frans A N Zoetmulder
Journal:  J Clin Oncol       Date:  2003-10-15       Impact factor: 44.544

9.  Prognostic value of CEA and CA 19-9 tumor markers combined with cytology from peritoneal fluid in colorectal cancer.

Authors:  In Kyu Lee; Do Hyoung Kim; D Lee Gorden; Yoon Suk Lee; Na Young Sung; Gyeoung-Sin Park; Hyung Jin Kim; Won Kyung Kang; Jong Kyung Park; Chang Hyeok Ahn; Jun-Gi Kim; Hae Myung Jeon; Seong Taek Oh
Journal:  Ann Surg Oncol       Date:  2009-02-03       Impact factor: 5.344

10.  Intraoperative spillage of tumor cells in surgery for rectal cancer.

Authors:  H Zirngibl; B Husemann; P Hermanek
Journal:  Dis Colon Rectum       Date:  1990-07       Impact factor: 4.585

View more
  1 in total

1.  CA125, CEA, CA19-9, and Heteroploid Cells in Ascites Fluid May Help Diagnose Peritoneal Carcinomatosis in Patients with Gastrointestinal and Ovarian Malignancies.

Authors:  Lin Deng; Shikong Guo; Hong Li; Xianghui You; Yang Song; Haichuan Su
Journal:  Cancer Manag Res       Date:  2020-10-22       Impact factor: 3.989

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.